WELLS FARGO & COMPANY/MN - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$12,383
-67.6%
5,578
-50.4%
0.00%
Q2 2023$38,250
+118.1%
11,250
+155.9%
0.00%
Q1 2023$17,540
+777.0%
4,396
+959.3%
0.00%
Q3 2022$2,0000.0%415
-28.6%
0.00%
Q2 2022$2,0005810.00%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
View complete list of TRANSPHORM INC shareholders